Vera Therapeutics
Vera Therapeutics is a clinical- and commercial-stage biopharmaceutical company based in Brisbane, California, developing treatments for serious immunological and inflammatory diseases of the kidney. Its lead program, atacicept (marketed as TRUTAKNA), is a dual BAFF/APRIL inhibitor for IgA nephropathy (IgAN). Surfaced as a portfolio company of GV and added to the API Evangelist network for enrichment, Vera Therapeutics publishes a corporate and patient-facing website (veratx.com) but exposes no public developer portal, API, SDKs, or machine-readable API surface. Sector: life-sciences.
Vera Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biopharmaceutical, Pharmaceuticals, and Nephrology.
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Clinical Trial Sponsors (drug pipelines) | standard | 56.0 | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.